Phoenix Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Phoenix Pharmaceuticals

Access the complete profile.

Phoenix Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	541711 Research & Development in Biotechnology
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	330 Beach Rd Burlingame, CA 94010

Note: Revenues for privately held companies are statistical evaluations.


Phoenix Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Phoenix Pharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Phoenix Pharmaceuticals is classified as operating in the Research & Development in Biotechnology industry, NAICS Code 541711.

Phoenix Pharmaceuticals Annual Revenue and Growth Rate

Phoenix Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Phoenix Pharmaceuticals's revenues are gauged from an analysis of company filings.

Phoenix Pharmaceuticals's Income Statement (based on Industry Averages)

Phoenix Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Phoenix Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Phoenix Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MARSHALL UNIVERSITY	Huntington, WV	100
SINCLAIR RESEARCH CENTER	Auxvasse, MO	44
NANOSCALE COMBINATORIAL SYNTHESIS	Santa Clara, CA	22
QUINTESSENTIAL BIOSCIENCES	Pleasant Grove, UT	20
TEXCELL - NORTH AMERICA	Frederick, MD	19
ETONBIO INC. DBA ETON BIOSCIENCE	San Diego, CA	16
NAVITAS CLINICAL RESEARCH	Rockville, MD	13
GENESIS BIOSCIENCES	Lawrenceville, GA	13
ARISE BIOSCIENCE	Boca Raton, FL	10

Nearby Competitors

These companies are similar in business line and location to Phoenix Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EMERALD THERAPEUTICS	South San Francisco, CA	100
PHARMACYCLICS	Sunnyvale, CA	59
ALTOS LABS	Redwood City, CA	39
NURO	Mountain View, CA	30
SRI INTERNATIONAL	Menlo Park, CA	27
EXPONENT	Menlo Park, CA	21

Future Competition: Phoenix Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Phoenix Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)